Denali Therapeutics Inc. PS Ratio 2017–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Current and historical P/S ratio for Denali Therapeutics Inc. (DNLI): market cap divided by trailing twelve-month revenue. As of September 30, 2024 it is 3896.04.

From: 06/30/2018To: 09/30/2024

Stock Price

TTM Revenue

PS Ratio

Denali Therapeutics Inc. PS Ratio — FAQ

Denali Therapeutics Inc. (DNLI) ps ratio over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see DNLI's ps ratio history?

The chart and table above show Denali Therapeutics Inc.'s ps ratio by year and by quarter, including the growth rate.